Mannose receptor induces T-cell tolerance via inhibition of CD45 and up-regulation of CTLA-4

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 38, 2016, Pages 10649-10654

  Schuette, Verena ^a   Embgenbroich, Maria ^a   Ulas, Thomas ^a   Welz, Meike ^b   Schulte Schrepping, Jonas ^a   Draffehn, Astrid M ^a   Quast, Thomas ^a   Koch, Katharina ^a   Nehring, Melanie ^a   König, Jessica ^a   Zweynert, Annegret ^a   Harms, Frederike L ^a   Steiner, Nancy ^a   Limmer, Andreas ^b   Förster, Irmgard ^a   Berberich Siebelt, Friederike ^c   Knolle, Percy A ^d   Wohlleber, Dirk ^d   Kolanus, Waldemar ^a   Beyer, Marc ^a   Schultze, Joachim L ^a   Burgdorf, Sven ^a   more..

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

CD45; Endocytosis receptors; T cell activation; Tolerance

Indexed keywords

CD45 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MANNOSE RECEPTOR; PHOSPHATASE; PROTEIN BCL 6; CELL SURFACE RECEPTOR; LECTIN; MANNOSE BINDING LECTIN; PTPRC PROTEIN, HUMAN; RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENDOCYTOSIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; TRANSCRIPTION INITIATION;

ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; CTLA-4 ANTIGEN; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; LECTINS, C-TYPE; LEUKOCYTE COMMON ANTIGENS; LYMPHOCYTE ACTIVATION; MANNOSE-BINDING LECTINS; MICE; PROTO-ONCOGENE PROTEINS C-BCL-6; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES, CYTOTOXIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84988640897     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1605885113     Document Type: Article

References (44)

1. Martinez-Pomares L (2012) The mannose receptor. J Leukoc Biol 92(6):1177-1186.
2. Burgdorf S, Kautz A, Böhnert V, Knolle PA, Kurts C (2007) Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 316(5824):612-616.
3. Luca ME, et al. (2005) Mannosylated PLP(139-151) induces peptide-specific tolerance to experimental autoimmune encephalomyelitis. J Neuroimmunol 160(1-2):178-187.
4. Kel J, et al. (2007) Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis. Am J Pathol 170(1):272-280.
5. Guimezanes A, et al. (2001) Identification of endogenous peptides recognized by in vivo or in vitro generated alloreactive cytotoxic T lymphocytes: Distinct characteristics correlated with CD8 dependence. Eur J Immunol 31(2):421-432.
6. Martinez-Pomares L, et al. (2006) Carbohydrate-independent recognition of collagens by the macrophage mannose receptor. Eur J Immunol 36(5):1074-1082.
7. Martínez-Pomares L, et al. (1999) Cell-specific glycoforms of sialoadhesin and CD45 are counter-receptors for the cysteine-rich domain of the mannose receptor. J Biol Chem 274(49):35211-35218.
8. Zehner M, et al. (2012) Intraendosomal flow cytometry: A novel approach to analyze the protein composition of antigen-loaded endosomes. Eur J Immunol 42(8):2187-2190.
9. Urbanek RA, et al. (2001) Potent reversible inhibitors of the protein tyrosine phosphatase CD45. J Med Chem 44(11):1777-1793.
10. Schietinger A, Delrow JJ, Basom RS, Blattman JN, Greenberg PD (2012) Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state. Science 335(6069):723-727.
11. Battke F, Symons S, Nieselt K (2010) Mayday-integrative analytics for expression data. BMC Bioinformatics 11:121.
12. Blackburn SD, et al. (2009) Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10(1):29-37.
13. Fathman CG, Lineberry NB (2007) Molecular mechanisms of CD4+ T-cell anergy. Nat Rev Immunol 7(8):599-609.
14. Hochweller K, Anderton SM (2005) Kinetics of costimulatory molecule expression by T cells and dendritic cells during the induction of tolerance versus immunity in vivo. Eur J Immunol 35(4):1086-1096.
15. Parish IA, et al. (2009) The molecular signature of CD8+ T cells undergoing deletional tolerance. Blood 113(19):4575-4585.
16. Safford M, et al. (2005) Egr-2 and Egr-3 are negative regulators of T cell activation. Nat Immunol 6(5):472-480.
17. Schwartz RH (2003) T cell anergy. Annu Rev Immunol 21:305-334.
18. Vang T, et al. (2008) Protein tyrosine phosphatases in autoimmunity. Annu Rev Immunol 26:29-55.
19. Williams O, Brady HJ (2001) The role of molecules that mediate apoptosis in T-cell selection. Trends Immunol 22(2):107-111.
20. Zheng Y, Zha Y, Gajewski TF (2008) Molecular regulation of T-cell anergy. EMBO Rep 9(1):50-55.
21. Fecteau S, et al. (2001) CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat Immunol 2(1):58-63.
22. Barbeau B, Robichaud GA, Fortin JF, Tremblay MJ (2001) Negative regulation of the NFAT1 factor by CD45: Implication in HIV-1 long terminal repeat activation. J Immunol 167(5):2700-2713.
23. Nurieva RI, et al. (2009) Bcl6 mediates the development of T follicular helper cells. Science 325(5943):1001-1005.
24. Baron BW, et al. (2007) Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas. Proc Natl Acad Sci USA 104(18):7449-7454.
25. Cerchietti LC, et al. (2010) A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo. Cancer Cell 17(4):400-411.
26. Burgdorf S, et al. (2010) Steady-state cross-presentation of OVA is mannose receptor-dependent but inhibitable by collagen fragments. Proc Natl Acad Sci USA 107(13):E48-E49, author reply E50-E51.
27. Segura E, Albiston AL, Wicks IP, Chai SY, Villadangos JA (2009) Different cross-presentation pathways in steady-state and inflammatory dendritic cells. Proc Natl Acad Sci USA 106(48):20377-20381.
28. Kohyama M, et al. (2009) Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature 457(7227):318-321.
29. Linehan SA, Martínez-Pomares L, Stahl PD, Gordon S (1999) Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: In situ expression of mannose receptor by selected macrophages, endothelial cells, perivascular microglia, and mesangial cells, but not dendritic cells. J Exp Med 189(12):1961-1972.
30. Franken L, et al. (2015) Splenic red pulp macrophages are intrinsically superparamagnetic and contaminate magnetic cell isolates. Sci Rep 5:12940.
31. van Vliet SJ, Gringhuis SI, Geijtenbeek TBH, van Kooyk Y (2006) Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45. Nat Immunol 7(11):1200-1208.
32. Chieppa M, et al. (2003) Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J Immunol 171(9):4552-4560.
33. Allavena P, et al. (2010) Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages. Clin Dev Immunol 2010:547179.
34. Longoni D, Piemonti L, Bernasconi S, Mantovani A, Allavena P (1998) Interleukin-10 increases mannose receptor expression and endocytic activity in monocyte-derived dendritic cells. Int J Clin Lab Res 28(3):162-169.
35. Schreiber S, et al. (1990) Prostaglandin E specifically upregulates the expression of the mannose-receptor on mouse bone marrow-derived macrophages. Cell Regul 1(5):403-413.
36. Shepherd VL, Abdolrasulnia R, Garrett M, Cowan HB (1990) Down-regulation of mannose receptor activity in macrophages after treatment with lipopolysaccharide and phorbol esters. J Immunol 145(5):1530-1536.
37. Harris N, Super M, Rits M, Chang G, Ezekowitz RA (1992) Characterization of the murine macrophage mannose receptor: Demonstration that the downregulation of receptor expression mediated by interferon-gamma occurs at the level of transcription. Blood 80(9):2363-2373.
38. Limmer A, et al. (2005) Cross-presentation of oral antigens by liver sinusoidal endothelial cells leads to CD8 T cell tolerance. Eur J Immunol 35(10):2970-2981.
39. van Vliet SJ, van Liempt E, Geijtenbeek TBH, van Kooyk Y (2006) Differential regulation of C-type lectin expression on tolerogenic dendritic cell subsets. Immunobiology 211(6-8):577-585.
40. Crotty S, Johnston RJ, Schoenberger SP (2010) Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation. Nat Immunol 11(2):114-120.
41. Yoshida K, et al. (2006) Bcl6 controls granzyme B expression in effector CD8+ T cells. Eur J Immunol 36(12):3146-3156.
42. Ariyan C, et al. (2003) Cutting edge: Transplantation tolerance through enhanced CTLA-4 expression. J Immunol 171(11):5673-5677.
43. Townsend A, et al. (1989) A mutant cell in which association of class I heavy and light chains is induced by viral peptides. Cold Spring Harb Symp Quant Biol 54(Pt 1):299-308.
44. Beyer M, et al. (2011) Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation. Nat Immunol 12(9):898-907.